These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24314751)

  • 1. Management of infections related to totally implantable venous-access ports: challenges and perspectives.
    Lebeaux D; Fernández-Hidalgo N; Chauhan A; Lee S; Ghigo JM; Almirante B; Beloin C
    Lancet Infect Dis; 2014 Feb; 14(2):146-59. PubMed ID: 24314751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of totally implantable venous-access port-related infections.
    Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
    Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
    Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
    J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the Implantation Technique for Totally Implantable Venous Access Ports (TIVAPs) Influence Long-Term Outcome?
    Biacchi D; Sammartino P; Sibio S; Accarpio F; Cardi M; Sapienza P; De Cesare A; Atta JM; Impagnatiello A; Di Giorgio A
    World J Surg; 2016 Feb; 40(2):284-90. PubMed ID: 26341511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the management of intravascular catheter-related infections.
    Mermel LA; Farr BM; Sherertz RJ; Raad II; O'Grady N; Harris JS; Craven DE;
    J Intraven Nurs; 2001; 24(3):180-205. PubMed ID: 11530364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
    Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term central venous catheter-related infections].
    Lebeaux D; Joly D; Zahar JR
    Rev Prat; 2014 May; 64(5):626-33. PubMed ID: 24923045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies for central venous catheter infections.
    Sabatier C; Ferrer R; Vallés J
    Expert Opin Pharmacother; 2009 Oct; 10(14):2231-43. PubMed ID: 19751104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infections related to central venous catheters in children affected from malignant diseases].
    Handrup MM; Møller JK; Schrøder H
    Ugeskr Laeger; 2011 Jun; 173(26):1882-5. PubMed ID: 21712011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections related to totally implantable venous-access ports.
    Del Pozo JL; Alonso M; de la Torre M; Aguinaga A
    Lancet Infect Dis; 2014 Aug; 14(8):676. PubMed ID: 25056016
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections related to totally implantable venous-access ports.
    Schreiber J
    Lancet Infect Dis; 2014 Aug; 14(8):676-677. PubMed ID: 25056015
    [No Abstract]   [Full Text] [Related]  

  • 14. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Totally implanted access port-related infections: features and management].
    Lebeaux D; Zarrouk V; Leflon-Guibout V; Lefort A; Fantin B
    Rev Med Interne; 2010 Dec; 31(12):819-27. PubMed ID: 20705372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A; Gatta C; Festini F
    Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placement and management of long-term central venous access catheters and ports.
    Denny DF
    AJR Am J Roentgenol; 1993 Aug; 161(2):385-93. PubMed ID: 8333382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of hemodialysis-related bloodstream infections.
    Camins BC
    Semin Dial; 2013; 26(4):476-81. PubMed ID: 23859190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections.
    Ince E; Oğuzkurt P; Temiz A; Ezer SS; Gezer HÖ; Yazici N; Hiçsönmez A
    Afr J Paediatr Surg; 2014; 11(2):138-42. PubMed ID: 24841014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.